Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death

Fig. 4

In vivo and in vitro, TDZD-8 treatment was able to regulate TRAF6, TAK1 and HDAC3 expression levels. A-C Expression of p-GSK3β, t-GSK3β, TAK1, TRAF6 and HDAC3 in liver tissues of each group of mice and their quantitative analysis. B and (D, E) Expression of p-GSK3β, t-GSK3β, TAK1, TRAF6 and HDAC3 in cells of each group and their quantitative analysis. F and (G) Immunofluorescence detection of localized expression of TAK1 in liver tissue and its mean fluorescence intensity statistics (magnification × 200). *P < 0.05 compare with control group, #P < 0.05 compare with model group

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us